Halozyme Therapeutics Stock Forward View - Accumulation Distribution
| HALO Stock | USD 78.42 0.49 0.63% |
Halozyme Stock outlook is based on your current time horizon. Although Halozyme Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Halozyme Therapeutics' systematic risk associated with finding meaningful patterns of Halozyme Therapeutics fundamentals over time.
As of today the rsi of Halozyme Therapeutics' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 0.362 | EPS Estimate Next Quarter 0.9562 | EPS Estimate Current Year 6.554 | EPS Estimate Next Year 8.18 | Wall Street Target Price 78 |
Using Halozyme Therapeutics hype-based prediction, you can estimate the value of Halozyme Therapeutics from the perspective of Halozyme Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Halozyme Therapeutics using Halozyme Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Halozyme using crowd psychology based on the activity and movement of Halozyme Therapeutics' stock price.
Halozyme Therapeutics Short Interest
An investor who is long Halozyme Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Halozyme Therapeutics and may potentially protect profits, hedge Halozyme Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 64.9347 | Short Percent 0.161 | Short Ratio 7.46 | Shares Short Prior Month 13.8 M | 50 Day MA 69.484 |
Halozyme Relative Strength Index
Halozyme Therapeutics Hype to Price Pattern
Investor biases related to Halozyme Therapeutics' public news can be used to forecast risks associated with an investment in Halozyme. The trend in average sentiment can be used to explain how an investor holding Halozyme can time the market purely based on public headlines and social activities around Halozyme Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Halozyme Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Halozyme Therapeutics.
Halozyme Therapeutics Implied Volatility | 0.42 |
Halozyme Therapeutics' implied volatility exposes the market's sentiment of Halozyme Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Halozyme Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Halozyme Therapeutics stock will not fluctuate a lot when Halozyme Therapeutics' options are near their expiration.
Halozyme Therapeutics after-hype prediction price | USD 78.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Halozyme Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Halozyme contract
Based on the Rule 16, the options market is currently suggesting that Halozyme Therapeutics will have an average daily up or down price movement of about 0.0263% per day over the life of the 2026-03-20 option contract. With Halozyme Therapeutics trading at USD 78.42, that is roughly USD 0.0206 . If you think that the market is fully incorporating Halozyme Therapeutics' daily price movement you should consider acquiring Halozyme Therapeutics options at the current volatility level of 0.42%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Halozyme Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Halozyme Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Halozyme Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Halozyme Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Halozyme Therapeutics' open interest, investors have to compare it to Halozyme Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Halozyme Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Halozyme. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Halozyme Therapeutics Additional Predictive Modules
Most predictive techniques to examine Halozyme price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Halozyme using various technical indicators. When you analyze Halozyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 58445.0 | 0.0236 |
| Check Halozyme Therapeutics Volatility | Backtest Halozyme Therapeutics | Information Ratio |
Halozyme Therapeutics Trading Date Momentum
| On February 07 2026 Halozyme Therapeutics was traded for 78.42 at the closing time. The top price for the day was 79.39 and the lowest listed price was 77.52 . There was no trading activity during the period 0.0. Lack of trading volume on February 7, 2026 did not cause price change. The trading delta at closing time against the current closing price is 1.15% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Halozyme Therapeutics to competition |
Other Forecasting Options for Halozyme Therapeutics
For every potential investor in Halozyme, whether a beginner or expert, Halozyme Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Halozyme Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Halozyme. Basic forecasting techniques help filter out the noise by identifying Halozyme Therapeutics' price trends.Halozyme Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Halozyme Therapeutics stock to make a market-neutral strategy. Peer analysis of Halozyme Therapeutics could also be used in its relative valuation, which is a method of valuing Halozyme Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Halozyme Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Halozyme Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Halozyme Therapeutics shares will generate the highest return on investment. By undertsting and applying Halozyme Therapeutics stock market strength indicators, traders can identify Halozyme Therapeutics entry and exit signals to maximize returns.
Halozyme Therapeutics Risk Indicators
The analysis of Halozyme Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Halozyme Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting halozyme stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.54 | |||
| Semi Deviation | 1.66 | |||
| Standard Deviation | 1.98 | |||
| Variance | 3.94 | |||
| Downside Variance | 3.76 | |||
| Semi Variance | 2.75 | |||
| Expected Short fall | (1.62) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Halozyme Therapeutics
The number of cover stories for Halozyme Therapeutics depends on current market conditions and Halozyme Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Halozyme Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Halozyme Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Halozyme Therapeutics Short Properties
Halozyme Therapeutics' future price predictability will typically decrease when Halozyme Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Halozyme Therapeutics often depends not only on the future outlook of the potential Halozyme Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Halozyme Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 129.4 M | |
| Cash And Short Term Investments | 596.1 M |
Check out Historical Fundamental Analysis of Halozyme Therapeutics to cross-verify your projections. To learn how to invest in Halozyme Stock, please use our How to Invest in Halozyme Therapeutics guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Will Biotechnology sector continue expanding? Could Halozyme diversify its offerings? Factors like these will boost the valuation of Halozyme Therapeutics. Market participants price Halozyme higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Halozyme Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.362 | Earnings Share 4.74 | Revenue Per Share | Quarterly Revenue Growth 0.221 | Return On Assets |
The market value of Halozyme Therapeutics is measured differently than its book value, which is the value of Halozyme that is recorded on the company's balance sheet. Investors also form their own opinion of Halozyme Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Halozyme Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Halozyme Therapeutics' market value can be influenced by many factors that don't directly affect Halozyme Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Halozyme Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Halozyme Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Halozyme Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.